BACKGROUND: In a recent US cohort study, total coffee and tea consumption was inversely associated with risk of glioma, and experimental studies showed that caffeine can slow the invasive growth of glioblastoma. OBJECTIVE: The objective was to examine the relation between coffee and tea intake and the risk of glioma and meningioma in a large European cohort study, the European Prospective Investigation into Cancer and Nutrition (EPIC). DESIGN: Data on coffee and tea intake were collected from men and women recruited into the EPIC cohort study. Over an average of 8.5 y of follow-up, 343 cases of glioma and 245 cases of meningioma were newly diagnosed in 9 countries. We used Cox proportional hazards models to examine the relation between coffee and tea and brain tumors. RESULTS: We observed no associations between coffee, tea, or combined coffee and tea consumption and risk of either type of brain tumor when using quantiles based on country-specific distributions of intake. However, a significant inverse association was observed for glioma risk among those consuming ≥100 mL coffee and tea per day compared with those consuming <100 mL/d (hazard ratio: 0.66; 95% CI: 0.44, 0.97; P = 0.03). The association was slightly stronger in men (hazard ratio: 0.59; 95% CI: 0.34, 1.01) than in women (hazard ratio: 0.74; 95% CI: 0.42, 1.31), although neither was statistically significant. CONCLUSIONS: In this large cohort study, we observed an inverse association between total coffee and tea consumption and risk of glioma that was consistent with the findings of a recent study. These findings, if further replicated in other studies, may provide new avenues of research on gliomas.
BACKGROUND: In a recent US cohort study, total coffee and tea consumption was inversely associated with risk of glioma, and experimental studies showed that caffeine can slow the invasive growth of glioblastoma. OBJECTIVE: The objective was to examine the relation between coffee and tea intake and the risk of glioma and meningioma in a large European cohort study, the European Prospective Investigation into Cancer and Nutrition (EPIC). DESIGN: Data on coffee and tea intake were collected from men and women recruited into the EPIC cohort study. Over an average of 8.5 y of follow-up, 343 cases of glioma and 245 cases of meningioma were newly diagnosed in 9 countries. We used Cox proportional hazards models to examine the relation between coffee and tea and brain tumors. RESULTS: We observed no associations between coffee, tea, or combined coffee and tea consumption and risk of either type of brain tumor when using quantiles based on country-specific distributions of intake. However, a significant inverse association was observed for glioma risk among those consuming ≥100 mL coffee and tea per day compared with those consuming <100 mL/d (hazard ratio: 0.66; 95% CI: 0.44, 0.97; P = 0.03). The association was slightly stronger in men (hazard ratio: 0.59; 95% CI: 0.34, 1.01) than in women (hazard ratio: 0.74; 95% CI: 0.42, 1.31), although neither was statistically significant. CONCLUSIONS: In this large cohort study, we observed an inverse association between total coffee and tea consumption and risk of glioma that was consistent with the findings of a recent study. These findings, if further replicated in other studies, may provide new avenues of research on gliomas.
Authors: Robert Dubrow; Amy S Darefsky; Neal D Freedman; Albert R Hollenbeck; Rashmi Sinha Journal: Cancer Causes Control Date: 2012-03-29 Impact factor: 2.506
Authors: Ning Li; Pingde Zhang; Karrie Mei Yee Kiang; Yin Stephen Cheng; Gilberto Ka Kit Leung Journal: Biomed Res Int Date: 2018-06-28 Impact factor: 3.411
Authors: Edwige Landais; Aurélie Moskal; Amy Mullee; Geneviève Nicolas; Marc J Gunter; Inge Huybrechts; Kim Overvad; Nina Roswall; Aurélie Affret; Guy Fagherazzi; Yahya Mahamat-Saleh; Verena Katzke; Tilman Kühn; Carlo La Vecchia; Antonia Trichopoulou; Elissavet Valanou; Calogero Saieva; Maria Santucci de Magistris; Sabina Sieri; Tonje Braaten; Guri Skeie; Elisabete Weiderpass; Eva Ardanaz; Maria-Dolores Chirlaque; Jose Ramon Garcia; Paula Jakszyn; Miguel Rodríguez-Barranco; Louise Brunkwall; Ena Huseinovic; Lena Nilsson; Peter Wallström; Bas Bueno-de-Mesquita; Petra H Peeters; Dagfinn Aune; Tim Key; Marleen Lentjes; Elio Riboli; Nadia Slimani; Heinz Freisling Journal: Nutrients Date: 2018-06-05 Impact factor: 5.717
Authors: Ai Seon Kuan; Jane Green; Cari M Kitahara; Amy Berrington De González; Tim Key; Gillian K Reeves; Sarah Floud; Angela Balkwill; Kathryn Bradbury; Linda M Liao; Neal D Freedman; Valerie Beral; Siân Sweetland Journal: Neuro Oncol Date: 2019-07-11 Impact factor: 12.300
Authors: Remo H M Furtado; Ramkumar V Venkateswaran; Jose C Nicolau; Yared Gurmu; Deepak L Bhatt; Robert F Storey; P Gabriel Steg; Giuglia Magnani; Shinya Goto; Mikael Dellborg; Gabriel Kamensky; Daniel Isaza; Philip Aylward; Per Johanson; Marc P Bonaca Journal: J Am Heart Assoc Date: 2020-05-15 Impact factor: 5.501